Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.26) per share. This is unchanged from the same period last year. The company reported quarterly sales of $4.25 million which beat the analyst consensus estimate of $3.72 million by 14.14 percent. This is a 6.60 percent decrease over sales of $4.55 million the same period last year.
S&P Makes Weekly Advance As Inflation Reaches Lowest Level Since March 2021; Amazon, Microsoft, Alphabet And Major Banks Lead Market Optimism
The S&P 500 is closing the week in the green in light of positive inflation data.
The index was 2.48% higher on the week ahead of the market close Friday. Other major market indexes also showed an upward trajectory, with the Dow Jones rising 2.36% on the week.
